申请人:Eckhardt Matthias
公开号:US20110312950A1
公开(公告)日:2011-12-22
This invention relates to novel compounds of the Formula Formulas (I), (Ia
1-20
), (Ib
1-20
), (Ic
1-20
), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11β-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of cortisol in a cell or the inhibition of the conversion of cortisone to cortisol in a cell.
本发明涉及公式(I),(Ia1-20),(Ib1-20),(Ic1-20)的新化合物,其药学上可接受的盐和药物组合物,用于治疗与哺乳动物中11β-HSD1调节或抑制相关的疾病。本发明还涉及新化合物的药物组合物和其在细胞中减少或控制皮质醇的产生或抑制皮质酮转化为皮质醇的方法。